Table 1.
Sociodemographic and clinicopathological characteristics in the study population.
| Variables | COVID-19 (n = 20) | H1N1 (n = 10) | CONTROL (n = 11) | p-value | ||
|---|---|---|---|---|---|---|
| COVID-19 vs H1N1 | COVID-19 vs CONTROL | |||||
| Age* | 70.7 ± 13.0 | 43.5 ± 13.9 | 42.3 ± 14.3 | <0.001c | <0.001a | |
| Gender† | Male | 13 (65.0) | 8 (80.0) | 8 (72.7) | 0.398b | 0.660b |
| Female | 7 (35.0) | 2 (20.0) | 3 (27.3) | |||
| Expression of IL-8§ | 0.89 (0.11–3.81) | 4.13 (0.72–9.13) | 0.00 (0.00–0.00) | <0.001a | <0.001a | |
| Expression of IL-17A§ | 2.65 (0.00–9.91) | 9.73 (4.34–15.44) | 0.00 (0.00–0.00) | <0.001c | <0.001a | |
| Neutrophil score§ | 2.5 (1.3–26.9) | 16.7 (11.4–25.8) | 3.2 (1.8–10.5) | <0.001a | 0.231 | |
| Mechanical ventilation (days)§ | 9 (0–36) | 1.5 (1–19) | — | 0.020a | — | |
| Time from hospitalization to death or survival time (days)§ | 11.5 (1–39) | 1.5 (1–19) | 4.0 (1–46) | 0.002a | 0.004a | |
*Mean ± Standard Deviation; †Absolute number (percentage); §Median (min-max); aMann-Whitney U; bPearson’s chi-square; cShapiro Wilk.